- Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
-
Kim HJ, Phak JH, Kim WC
- KMID: 2366046
- Radiat Oncol J.
- 2016 Dec;34(4):260-264.
- doi: 10.3857/roj.2015.01571
PURPOSE: Stereotactic body radiotherapy (SBRT) takes advantage of low α/β ratio of prostate cancer to deliver a large dose in few fractions. We examined clinical outcomes of SBRT using CyberKnife... -
- CITED
-
- Close
- SHARE
-
- Close
